Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Knowledge-based planning for multi-isocenter VMAT total marrow irradiation.
Rowell, Susan
Minimally Invasive Treatment for Unicameral Bone Cysts with Chemical Sclerosis and Bone Graft Substitute: A Preliminary Report.
Complete Genome Sequence of Enterococcus faecium ATCC 700221.
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer.
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer. J Med Chem. 2016 Jan 14; 59(1):219-237.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents, Hormonal
Breast Neoplasms
Cell Line, Tumor
Drug Design
Drug Resistance, Neoplasm
Estrogen Receptor alpha
Female
Humans
Mice
Models, Molecular
Selective Estrogen Receptor Modulators
Structure-Activity Relationship
Tamoxifen
Uterus
Xenograft Model Antitumor Assays
authors with profiles
Jiong Zhao